MSICS Pharma
PrivateLast Round
Seed
May 6, 2026
Total Funding Raised
$7.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MSICS Pharma is a biotechnology company developing medical-grade technology to grow and produce psilocybin for the treatment of mental health conditions such as PTSD, depression, and OCD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MSICS Pharma Comparables
Compare MSICS Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xentria, Inc. | 78% | |
| Roivant Sciences | 77% | |
| SarcoMed USA | 76% |
MSICS Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 6, 2026 | ||||
| Seed | Apr 5, 2026 |
MSICS Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FUSION | Seed |
| GlenRock Israel | Seed |
| SGL Acquisitions | Seed |
| L& Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
$3.6M round led by FUSION.
- Apr 5, 2026
$3.6M round led by GlenRock Israel, FUSION, and SGL Acquisitions.
MSICS Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MSICS Pharma's valuation, stock price, and market status.
Is MSICS Pharma a public or private company?
MSICS Pharma is a private company.
What is the current stock price of MSICS Pharma?
MSICS Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is MSICS Pharma worth (valuation)?
Valuation information for MSICS Pharma is not publicly available.
Can I buy MSICS Pharma stock?
MSICS Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MSICS Pharma's last funding round?
MSICS Pharma's most recent funding round was Seed on May 6, 2026.
Who are the main investors in MSICS Pharma?
Key investors in MSICS Pharma include FUSION, GlenRock Israel.
Will MSICS Pharma IPO soon?
No public IPO plans have been announced for MSICS Pharma.
How can I track MSICS Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MSICS Pharma's secondary market activity and sign up for updates.